For research and educational purposes only. Not medical advice.
Alpha-GPC Reference
Educational, not medical advice reference for Alpha-GPC: Nootropic, Cognitive; regulatory status, evidence posture, source review, and schedule notes. Also k…
Reference summary
Italian clinical literature in cognitive impairment / vascular dementia. Smaller US literature in athletic-performance / power-output trials.
- Categories
- Nootropic, Cognitive
- Aliases
- L-alpha glycerylphosphorylcholine, Choline alfoscerate
- Evidence posture
- human — Sold as a dietary supplement in the US, not as an FDA-approved drug. Effects on cognition or power output are studied in small trials with mixed quality. Not a treatment.
- Regulatory status
- No FDA-approved alpha-GPC drug label in the US. Sold as a dietary supplement (FDA-NDI on file) and as a prescription drug in some non-US markets (e.g., Italy under Gliatilin) for cognitive impairment.
- Content review status
- research reference